GALVESTON, Texas--(BUSINESS WIRE)--Chrysalis BioTherapeutics, Inc. announced today that the US Food and Drug Administration (FDA) has given the company permission to initiate human clinical trials ...
Engineers have conceptualized Chrysalis, a rotating spacecraft designed for interstellar travel to Alpha Centauri. This ambitious project, winner of the Project Hyperion Design Competition, envisions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback